Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9872900 Nucleic acid vaccines

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
April 5, 2016
Date of Patent
January 23, 2018
Patent Application Number
15091123
Patent Citations Received
‌
US Patent 12133899 Coronavirus vaccine
0
‌
US Patent 12103955 Polynucleotides encoding relaxin
0
‌
US Patent 12109274 Polynucleotides containing a stabilizing tail region
0
‌
US Patent 12128113 Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
0
‌
US Patent 11696946 Influenza vaccine
0
‌
US Patent 11701434 Tertiary amino lipidated cationic peptides for nucleic acid delivery
0
‌
US Patent 11708572 Acoustic cell separation techniques and processes
0
‌
US Patent 11744801 Methods of making lipid nanoparticles
‌
US Patent 11746143 Methods to identify immunogens by targeting improbable mutations
‌
US Patent 11752206 Herpes simplex virus vaccine
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9872900
Patent Primary Examiner
‌
Benjamin P Blumel

Find more entities like US Patent 9872900 Nucleic acid vaccines

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo